• Policy
• NHI big data was used to evaluate safety of JAK inhibitors
• by Lee, Tak-Sun Nov 2, 2022 05:36am

• Policy
• "Synthetic Biology" that Moderna used
• by Kang, Shin-Kook Nov 2, 2022 05:36am

• Company
• Hanmi achieves record quarterly performance in 7 years
• by Chon, Seung-Hyun Nov 2, 2022 05:36am

• Product
• A fierce battle between MDs & RPhs on Rx of ingredient names
• by Kang, Shin-Kook Nov 2, 2022 05:36am

• Company
• JW signs new anti-cancer drug R&D contract with KURE AI
• by Nho, Byung Chul Nov 2, 2022 05:35am

• Company
• RET-targeted Retevmo reattempts reimb listing in Korea
• by Eo, Yun-Ho Nov 1, 2022 06:02am

• Policy
• LG Chemical completed Vimovo's domestic copyright
• by Lee, Tak-Sun Nov 1, 2022 06:02am

• Company
• Bukwang applies for approval of Lurasidone
• by Nov 1, 2022 06:02am

• Policy
• It doesn't mean that we're considering a reduction
• by Lee, Tak-Sun Nov 1, 2022 06:02am

• Policy
• Gov’t to fully investigate its COVID-19 research support
• by Lee, Tak-Sun Nov 1, 2022 06:02am